Related Experiment Video
Updated: Aug 17, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
Highly potent anti-HIV-1 activity isolated from fermented Polygonum tinctorium Aiton
Yu Zhong1, Yoshiyuki Yoshinaka, Tadahiro Takeda
1Department of Molecular Virology, Bio-Response, Graduate School, Tokyo Medical and Dental University, 1-5-45, Yushima, Tokyo 113-8519, Japan.
Abstract:
A water-soluble extract of fermented Polygonum tinctorium Aiton (Polygonaceae) called Sukumo, exhibited a potent inhibitory activity against HIV type 1 in vitro. The extract potently suppressed acute HIV-1 (IIIB) infection in MT-4 cells with EC50 values of 0.5 microg/ml but exhibited low cytotoxicity to MT-4 cells even at a high concentration (CC50 > 1000 microg/ml). It also inhibited giant cell formation in co-cultures of HIV-infected cells and uninfected Molt-4 cells. Sukumo extract was found to interact with both the viral envelope glycoprotein and cellular receptors, thus blocking virus-cell binding and virus-induced syncytium formation. There was a good correlation between the extract's anti-HIV-1 activity and its inhibitory effects on HIV-1 binding. It also suppressed replication of herpes simplex virus type 1 in Vero cells with an EC 50 of 11.56 microg/ml. On the other hand, there was no appreciable activity against influenza A virus, poliovirus or SARS corona virus when tested at concentrations ranging from 3.2-400 microg/ml as shown by microscopic image analysis for cytopathic effect (CPE). Physico-chemical studies revealed that the anti-HIV activity in the extract was essentially maintained after boiling at 100 degrees C in 1N HCl or 1N NaOH, and after treatment with 100 mM NaIO4. The inhibitory activity of the extract was also not reduced after pronase digestion. The active factor in the extract is likely to be a novel compound(s) having a polyanionic substructure and a molecular weight of 10,000-50,000.
Insights
A fermented Polygonum tinctorium extract, Sukumo, shows potent anti-HIV-1 activity by blocking viral binding to cells. This natural compound also inhibits herpes simplex virus type 1, offering potential for antiviral therapies.
Area of Science:
- * Phytochemistry
- * Virology
- * Immunology
Background:
- * Human Immunodeficiency Virus (HIV) remains a significant global health challenge.
- * Natural products are explored for novel antiviral agents.
- * Polygonum tinctorium (Sukumo) is a fermented plant extract with potential medicinal properties.
Purpose of the Study:
- * To investigate the in vitro antiviral activity of Sukumo extract.
- * To determine the mechanism of action against HIV-1.
- * To assess activity against other viruses like herpes simplex virus type 1.
Main Methods:
- * In vitro assays using MT-4 cells for HIV-1 infection and cytotoxicity.
- * Co-culture assays to observe giant cell formation (syncytia).
- * Physico-chemical treatments (boiling, acid/base, enzyme digestion) to characterize active components.
Main Results:
- * Sukumo extract potently inhibited HIV-1 (IIIB) infection (EC50 = 0.5 microg/ml) with low cytotoxicity (CC50 > 1000 microg/ml).
- * The extract blocked HIV-1 binding to cells and inhibited syncytium formation.
- * Significant activity was observed against herpes simplex virus type 1 (EC50 = 11.56 microg/ml).
- * No significant activity was found against influenza A, poliovirus, or SARS-CoV.
Conclusions:
- * Sukumo extract possesses potent antiviral properties, particularly against HIV-1 and HSV-1.
- * The mechanism involves blocking virus-cell interaction.
- * The active compound is likely a heat-stable, polyanionic molecule with a molecular weight of 10,000-50,000.
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Inhibitors of Virion Maturation and Assembly

